Table of Contents How GLP-1 Medications Affect Taste and Food Preferences Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
As well as stimulating insulin release, GLP-1R agonists promote satiety and reduce food intake, leading to weight loss
After four weeks with no changes to macros or training, bioimpedance scanning showed 6.3 pounds of fat loss and 1.1 pounds of lean mass gain simultaneously
Just this past August, semaglutide was approved for treating metabolicassociated steatohepatitis, formerly known as fatty liver disease, says Dr